Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Doses of GLPG1972 for 4 Weeks in Subjects With Osteoarthritis.
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2017
At a glance
- Drugs GLPG 1972 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Galapagos NV
- 21 Nov 2017 Status changed from active, no longer recruiting to completed.
- 15 Oct 2017 Status changed to active, no longer recruiting.
- 20 Jun 2017 Completion of patient recruitment is expected by the end of 2017 according to a Galapagos media release.